Table 1 Details of all patients included in the study

From: Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma

 

N

%

Characteristic

Normal

Total

60

100

Sex

 Male

38

63.3

 Female

22

36.7

Age (years)

 Median (range)

63 (27, 82)

 
 

Benign

Total

30

100

Sex

 Male

19

63.3

 Female

11

36.7

Age (years)

 Median (range)

58 (34, 84)

 

Condition

 Urinary tract infection

4

13

 Benign prostatic hypertrophy

3

10

 Renal stone

12

40

 Cystic disease

4

13

 Benign renal tumoura

6

20

 Renal atrophy

1

4

 

RCC

Total

149

100

Sex

 Male

94

63.1

 Female

55

36.9

Age (years)

 Median (range)

61 (37, 85)

 

pTumour diameter (cm)

 Median (range)

6 (2.0, 15.5)

 

CT Tumour diameter (cm)

 Median (range)

6 (2.0, 21)

 

Grade

 1

3

2.0

 2

33

22.2

 3

73

49.0

 4

40

26.8

Sarcomatoid change

 No

137

91.9

 Yes

12

8.1

pT stage

 1a

31

20.8

 1b

32

21.5

 2

14

9.4

 3a

27

18.1

 3b

42

28.2

 4

3

2.0

CT T stage

 1a

35

27.3

 1b

38

29.7

 2

31

24.2

 3a

19

14.8

 4

5

3.9

N stage

 0

132

88.6

 1

17

11.4

M stage

 0

111

74.5

 1

38

25.5

TNM stage

 I

58

38.9

 II

10

6.7

 III

42

28.2

 IV

39

26.2

Symptoms

 Local

63

43.2

 Asymptomatic

49

33.6

 Systemic

34

23.3

Relapse

 No

76

65.5

 Yes

40

34.5

Cancer death

 No

112

75.2

 Yes

37

24.8

Death from any cause

 No

94

63.1

 Yes

55

36.9

  1. Abbreviation: CC=renal cell carcinoma.
  2. a3 × oncocytoma, 1 × metanephric adenoma, 1 × cystic nephroma, 1 × inflammatory pseudotumour.